797.00
+4(+0.50%)
Currency In JPY
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
289
First IPO Date
June 21, 2018
| Name | Title | Pay | Year Born |
| Mr. Toshiyuki Shuto | President, Chief Executive Officer & Chairman of the Board of Directors | 0 | 1947 |
| Mr. Toshihiro Hirono | MD & Director | 0 | 1949 |
| Mr. Miyoko Komatsu | MD of Finance & Accounting and Director | 0 | 1964 |
| Ms. Ritsuko Ohtsuka | Executive Vice President, MD, Sustainability Officer & Director | 0 | 1978 |
| Mr. Toshinori Koyama | Executive MD of Sales & Director | 0 | 1948 |
| Mr. Teruyuki Tanaka | Director of Business Development & Corporate Planning & Director | 0 | 1950 |
| Yuki Toyoda | Executive Officer & GM of the General Affairs Department | 0 | N/A |
Koa Shoji Holdings Co.,Ltd., through its subsidiaries, imports and sells APIs/intermediates in Japan. It is also involved in the manufacture and marketing of various injections; OTC drugs, primarily various vitamins; and manufacture and sale of generic drugs. In addition, the company engages in contract manufacturing of pharmaceuticals; and packaging of pharmaceutical products. Koa Shoji Holdings Co.,Ltd. was founded in 1991 and is headquartered in Yokohama, Japan.